Fortress Biotech Inc (FBIO) — Capital Reinvestment Ratio

Latest as of December 2015: 3.72x

Fortress Biotech Inc (FBIO) has a Capital Reinvestment Ratio of 3.72x as of December 2015, meaning it reinvests 4% of its operating cash flow ($2.86 Million) in capital expenditures ($10.64 Million). See debt-free asset ratio of Fortress Biotech Inc to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

3.72x

Capex / Operating Cash Flow

Operating Cash Flow

$2.86 Million

USD

Capital Expenditures

$10.64 Million

USD

Data as of

Dec 2015

Most recent filing

Annual Capital Reinvestment Ratio for Fortress Biotech Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Fortress Biotech Inc from None to None. For live market cap and broader valuation context, see Fortress Biotech Inc (FBIO) total market value.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow